Company Number: 14285836

Analysis Date: 2025-07-20 16:19 UTC

Financial Health Assessment of KAPRA FALCONERI LIMITED

---

1. Financial Health Score: C

Explanation:
The company shows early-stage growth characteristics with positive net current assets and net assets, indicating basic financial stability. However, the very low cash balance combined with a significant increase in current liabilities—especially directors’ loan accounts—and modest turnover levels suggest liquidity strain and reliance on internal financing. This score reflects a business that is stable but exhibits symptoms of financial stress that need to be managed carefully.

---

2. Key Vital Signs

Metric	2024 (£)	2023 (£)	Interpretation
Turnover	Not disclosed for 2024, £25,058 (2023)	£25,058 (2023)	Small revenue base, typical for a young company; limited sales scale at this stage.
Current Assets	70,516	11,112	Large increase mainly due to stocks (£52,364); indicates inventory buildup which ties up cash.
Cash at Bank	76	4,463	Critically low cash balance in 2024; potential liquidity red flag, despite positive net working capital.
Debtors	18,076	6,649	Higher receivables may reflect growth or slower collections; impacts cash flow.
Current Liabilities	60,796	4,891	Sharp rise due mainly to directors’ loan accounts (£53,225); reliance on internal funding sources.
Net Current Assets	9,720	6,221	Positive but modest working capital; current assets cover short-term liabilities with a small buffer.
Net Assets / Shareholders' Funds	9,720	6,221	Positive equity indicates solvency; growth in retained earnings is a good sign.
Employees	0	0	No employees recorded; likely reliant on directors or outsourced labor.

---

3. Diagnosis: What the Financial Data Reveals

KAPRA FALCONERI LIMITED is a very young private limited company operating in retail and wholesale trade. The company appears to be in the initial growth phase, with turnover reported in 2023 but no turnover details disclosed for the latest year. The balance sheet shows a significant increase in inventory (stocks) and debtors, suggesting the company is building up its operational capacity but with cash flow constraints.

The extremely low cash position (£76 at 2024 year-end) contrasts with growing liabilities, particularly directors' loan accounts, which have ballooned to over £53,000. This shows the company is relying heavily on loans from directors to finance its operations—a "symptom of distress" in cash management terms. While net current assets remain positive, the liquidity is tight, raising concerns around day-to-day operational cash flow.

No employees are reported, which may indicate a lean operational setup but could also signal limitations in scaling. The shareholders’ funds show a modest increase, indicating retained profits or capital injections, which is a healthy sign for solvency.

Overall, the company is solvent but exhibits early warning signs of strained liquidity and dependency on director financing. This is common in startups but requires careful management to avoid cash flow crisis.

---

4. Recommendations: Specific Actions for Financial Wellness

• Improve Cash Flow Management:
  Implement tighter controls on receivables collection and inventory turnover to free up cash. Consider negotiating better payment terms with suppliers and customers.

• Reduce Reliance on Directors’ Loans:
  Explore external financing options such as bank loans, invoice financing, or equity investment to alleviate pressure on directors and diversify funding sources.

• Monitor Stock Levels Closely:
  The build-up of stocks ties up cash unnecessarily. Adopt just-in-time inventory or sales forecasting to optimize stock and reduce holding costs.

• Increase Sales and Revenue:
  Focus on marketing and sales strategies to grow turnover, which will improve operating cash inflows and reduce liquidity risk.

• Prepare for Audit and Compliance:
  Though currently exempt, as the company grows, ensure accounting processes are robust and consider voluntary audits to enhance financial credibility with lenders or investors.

• Financial Forecasting and Budgeting:
  Develop detailed cash flow forecasts to anticipate future liquidity needs and plan accordingly.

---

Medical Analogy Summary

The company’s financial statements reveal a "young patient" with stable but fragile "vital signs." The positive net assets are encouraging—akin to a strong heartbeat—but the dangerously low cash reserves and reliance on directors' loans resemble symptoms of "circulatory strain" that could escalate into financial distress if not treated promptly. With careful management, this business can strengthen its "financial immunity" and grow into a healthy, self-sustaining enterprise.

---